[Therapy with anticoagulants and platelet aggregation inhibitors in extracranial vascular stenoses and occlusions].
D000925:Anticoagulants / Q000627:therapeutic use*; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000517:prevention & control; D002561:Cerebrovascular Disorders / Q000517:prevention & control; D004176:Dipyridamole / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D010974:Platelet Aggregation / Q000187:drug effects; D013442:Sulfinpyrazone / Q000627:therapeutic use*; D013923:Thromboembolism / Q000517:prevention & control
D000925:Anticoagulants; D004176:Dipyridamole; D006493:Heparin; D001241:Aspirin; D013442:Sulfinpyrazone
Therapie mit Antikoagulantien und Thrombozytenaggregationshemmern bei extrakraniellen Gefässstenosen und Gefässverschlüssen.